Phyllanthus
Phyllanthus, licence 80040929: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Adhyana, Arrebenta Pedras, Bhui amla, Bhumi-Amla, Carry-Me-Seed, Chanca Piedra, Chancapiedra, Erva Pombinha, Niruri, Phyllanthus niruri
- Licence holder
- Groupe BNA Consultant
- NPN or DIN-HM
- 80040929
- Status
- Active licence
- Licence date
- 15 March 2013
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Glycérine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 mL | minimum: 2.0 Jour(s) ; maximum: 3.0 Jour(s) |
Uses authorised in Canada
Traditionnellement utilisé en phytothérapie Ayurvédique pour aider à soulager la dyspepsie et/ou comme diurétique pour aider à soulager les infactions légères des voies urinaires.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ne pas utiliser si vous êtes enceinte ou si vous allaitez. Consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Consulter un praticien de soins de santé si vous souffrez de diabète ou si vous prenez des médicaments pour contrôler les niveaux sanguins de glucose.
- Contre-indications
Consulter un praticien de soins de santé avant utilisation si vous avez le diabète ou des troubles cardiaques.
Source
Official Health Canada record, licence 80040929
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.